NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
WednesdayFeb 15, 2017 10:45 am

NABUFIT Global, Inc. (NBFT) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

NABUFIT Global (OTCQB: NBFT) is an online fitness platform for health and well-being through physical exercises, nutrition and lifestyle. The platform offers an interactive, customized experience founded on the workouts and participation of Sports Stars, including Neymar Jr., Mo Farah, Peter Schmeichel, Michael Maze, and many more to come. The development, headquartered in Denmark, is developing an online fitness platform and a mobile application that connects to existing and future monitoring devices such as wearables. For more information, visit the company’s website at: www.nabufit.com About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

Continue Reading

WednesdayFeb 15, 2017 10:45 am

IntelliPharmaCeutics International (NASDAQ: IPCI) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

IntelliPharmaCeutics International (NASDAQ: IPCI) is a pharmaceutical company that engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The company develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in various stages of development in therapeutic areas, such as neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. Its lead product is Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for attention deficit hyperactivity disorders. For more information, visit the company's website at www.intellipharmaceutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

WednesdayFeb 15, 2017 10:00 am

Lantronix (NASDAQ: LTRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Lantronix (NASDAQ: LTRX) is a specialized networking company providing smart Internet of Things (IoT) and machine-to-machine (M2M) solutions. The company's innovative products deliver secure connectivity, device management, and mobility for today's increasingly connected world. By networking and managing devices and machines that have never before been connected, Lantronix's connectivity solutions are deployed inside millions of machines serving a wide range of industries, including data center, medical, security, industrial, transportation, retail, financial, environmental and government. For more information, visit the company's website at www.lantronix.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

WednesdayFeb 15, 2017 10:00 am

CytoSorbents Corp. (NASDAQ: CTSO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

CytoSorbents (NASDAQ: CTSO) is a critical care focused immunotherapy company engaged in the research, development and commercialization of medical devices with its platform blood purification technology that incorporates a proprietary adsorbent polymer technology. Its principal product is the CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis. CytoSorbent is also developing the HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients. For more information, visit the company’s website at www.cytosorbents.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

Continue Reading

WednesdayFeb 15, 2017 10:00 am

ITUS (NASDAQ: ITUS) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

ITUS (NASDAQ: ITUS) funds, develops, acquires and licenses emerging technologies in the areas of biotechnology. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek, a series of non-invasive, blood tests for the early detection of solid tumor based cancers. It has a collaborative research agreement with The Wistar Institute for the development and validation of Cchek. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. For more information, visit the company's website at www.ituscorp.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

Continue Reading

WednesdayFeb 15, 2017 9:30 am

Check-Cap Ltd. (NASDAQ: CHEK) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Check-Cap (NASDAQ: CHEK) is a clinical-stage medical diagnostics company developing the world's first ingestible capsule system for preparation-free, less-invasive colorectal cancer screening. The capsule utilizes innovative ultra-low dose X-ray and wireless communication technologies to scan the inside of the colon as it moves naturally, while the patient follows his or her normal daily routine.  After passage, the system generates a 3D map of the inner surface of the colon which enables detection of polyps and cancer.  Designed to increase the willingness of individuals to participate in recommended colorectal cancer screening, the Check-Cap system addresses many frequently-cited barriers, including laxative bowel preparation,…

Continue Reading

WednesdayFeb 15, 2017 9:30 am

Chanticleer Holdings, Inc. (NASDAQ: HOTR) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Chanticleer Holdings (NASDAQ: HOTR) is a leading company that owns, operates and franchises fast casual and full service dining concepts in the United States and internationally. Chanticleer owns and operates restaurants under the Hooters, American Burger Company, The Burger Joint, BT’s Burger Joint, Little Big Burger, and Just Fresh names. For more information, visit the company’s website at www.chanticleerholdings.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned…

Continue Reading

WednesdayFeb 15, 2017 9:00 am

VolitionRx Ltd. (NYSE: VNRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

VolitionRx (NYSE: VNRX) is a clinical-stage life sciences company focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is involved in the development of 28 epigenetic NuQ blood assays based on its Nucleosomics biomarker discovery platform. VolitionRx develops two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer by detecting nucleosomes containing specific histone variants. The company also develops 17 blood assays in the NuQ-M family to detect cancer by detecting nucleosomes containing…

Continue Reading

WednesdayFeb 15, 2017 9:00 am

Auxilio, Inc. (AUXOD) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Auxilio (OTCQB: AUXOD) provides complete document workflow solutions and IT security services to healthcare organizations across the United States. The company has helped its clients save more than $80 million since 2004 by providing solutions which lower costs, improve operational efficiency and enhance security. Auxilio’s iPLATFORM, an intelligent workflow automation suite delivers a customer driven, vendor neutral approach to secure patient health information, reduce waste and drive additional savings opportunities. Auxilio serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices supporting over 280,000 caregivers. For more information, visit the…

Continue Reading

WednesdayFeb 15, 2017 9:00 am

Northwest Biotherapeutics (NWBO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Northwest Biotherapeutics (OTCQB: NWBO) is focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe.  The company's lead program is a 331-patient phase III trial in newly diagnosed Glioblastoma multiforme (GBM).  GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease."  Northwest is also pursuing a phase I/II trial with DCVax-Direct for all types of inoperable solid tumor cancers.  It has completed the 40-patient phase I portion of the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright 2015 - 2025. NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers